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a  b  s  t  r  a  c  t
To  reinforce  skin  protection  against  organophosphates  (OPs),  the  development  of new  topical  skin  pro-
tectants (TSP)  has received  a great  interest.  Nanoparticles  like  cerium  dioxide  (CeO2)  known  to adsorb
and  neutralize  OPs  are  interesting  candidates  for  TSP.  However,  NPs  are  difﬁcult  to  disperse  into  for-
mulations  and  they  are  suspected  of toxicological  issues.  Thus,  we  want  to  study:  (1)  the  effect  of  the
addition  of  CeO2 NPs  in  formulations  for  the  skin  protection  (2) the  impact  of the doping  of  CeO2 NPs
by  calcium;  (3)  the effect  of two methods  of  dispersion  of CeO2 NPs:  an O/W  emulsion  or  a suspension
of a ﬂuorinated  thickening  polymer  (HASE-F)  grafted  with  these  NPs.  As a screening  approach  we  used
silicone  membranes  as a skin  equivalent  and  Franz  diffusion  cells  for  permeation  tests.  The  addition  oferium dioxide
anoparticles
hickening polymers
pure  CeO2 NPs  in both  formulations  permits  the  penetration  to decrease  by  a  3–4-fold  factor.  The  O/W
emulsion  allows  is  the  best approach  to obtain  a ﬁlm-forming  coating  with  a good  reproducibility  of
the  penetration  results;  whereas  the  grafting  of  NPs  to  a thickener  is the  best  way  to obtain  an  efﬁcient
homogenous  suspension  of CeO2 NPs  with  a decreased  of  toxicological  impact  but the coating  is  less
ﬁlm-forming  which  slightly  impacts  the reproducibility  of  the penetration  results.
©  2015  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Human exposure to organophosphates (OPs) can occur in
omestic, occupational and incidental contexts. [1–3]. They are
sed as pesticides (parathion, malathion, etc.) [4] and the most
oxic of them are part of chemical warfare agents (CWA) (sarin,
X, etc.) [5]. They inhibit acetylcholinesterases (AChE) present in
he central and peripheral nervous system. This results in an accu-
ulation of the acetylcholine (ACh) neurotransmitter that causes
aralysis, suffocation and death [5]. The main exposure routes
o OPs are respiratory and dermal. Percutaneous penetration can
ccur for the most persistent of them such as the CWA  VX and
he pesticide parathion and its oxidized derivative paraoxon (POX)
6–8]. As a consequence, speciﬁc protective equipments (suits, face
asks, gloves and boot covers) were developed to limit skin con-
act and absorption of these highly toxic chemicals [9]. However,
∗ Corresponding author.
E-mail address: guittard@unice.fr (F. Guittard).
ttp://dx.doi.org/10.1016/j.toxrep.2015.07.003
214-7500/© 2015 Published by Elsevier Ireland Ltd. This is an open access article under license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
they are not adapted to all situations and need to be perfectly
adjusted [10]. To reinforce skin protection, topical skin protectants
(TSP) or barrier creams (BC) mainly constituted of perﬂuorinated
polymers and reactive compounds have received a great inter-
est [11–16]. Nanoparticles (NPs) materials such as silica, titanium
oxide or cerium oxide have been studied for their capacity to adsorb
and neutralize toxic compounds including OPs [11,13,15,17–27].
In particular, cerium dioxide (CeO2) NPs that are used in many
ﬁelds (solar cells [28], as catalysts [29] and ultraviolet absorbents)
[30–32] were demonstrated to hydrolyse phosphate ester bonds
[33]. Moreover, it has been shown that the doping of CeO2 NPs
by calcium modify their structure and their physicochemical prop-
erties resulting in an increase of their UV ﬁltration [32]. These
modiﬁcations could also be interesting for our purpose. Then, the
introduction of CeO2 or calcium doped-CeO2 (Ca2+-CeO2) NPs into
emulsions could be a new way  to improve the TSP efﬁcacy against
OPs [32,34].
Due to potential aggregation of NPs in emulsion, their
skin permeation and potential toxicity [35–40], another inno-
vative way is to graft them onto thickening polymers [41].
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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oFig. 1. Grafting of amine-function
hickeners are associative polymers such as hydrophobically mod-
ﬁed alkali-soluble emulsion (HASE) that have the ability to form
hree-dimensional network gels in aqueous solution. The backbone
f these copolymers is constituted of methacrylic acid (MA), ethyl
crylate (EA) and a small amount of associative macromonomer
M). The macromonomer contains a hydrophobic pendant group
eparated from the backbone by a polyethylene glycol (PEG) spacer
hain. These thickening agents typically combine two  properties:
he solubility in alkaline solution due to the presence of carboxylic
roups that ionise and provoke an increase of hydrodynamic vol-
me, and the existence of Van der Walls interactions between the
olymeric chains for an increase of the aqueous solution viscosity
42–44]. The substitution of hydrocarbon moieties into ﬂuorinated
nes in the copolymer leads to very low surface tension copoly-
ers, and often improves the dispersibility of nanoparticles in
ater [42,43,45–48]. Our recent works demonstrated that the total
eplacement of ethyl groups in an HASE skeleton by triﬂuoroethyl
roups (HASE-F polymer) leads to solutions with a thickening effect
quivalent to the reference hydrocarbon HASE [49]. The cova-
ent grafting of NPs on HASE polymers allows the creation of a
anoparticular network [41] which can (1) combine both protec-
ive/decontamination effects of ﬂuorinated polymers and NPs and
2) decrease NPs impact on the environment [50].
In this work, our goals were: (1) to observe the impact of the
oping of CeO2 NPs by calcium for the skin protection against OPs;
nd (2) to determine the effect of two dispersion methods on the
ffectiveness of CeO2 NPs. The efﬁcacy of two CeO2 NP-based top-
cal formulations was evaluated: in the ﬁrst one, CeO2 NPs were
ispersed in an O/W emulsion; in the second one, NPs were grafted
nto a ﬂuorinated HASE thickener polymer (HASE-F) (Fig. 1). CeO2 NPs to the HASE-F polymer.
Millerioux et al. [6,7] showed that in vitro permeation tests using
silicone membranes are suitable as ﬁrst screen tests to select poten-
tially effective TSP against toxic chemicals agents. Thus, efﬁcacy test
were performed with in vitro Franz-type glass diffusion cells using
silicone membranes as a support matrix representing the skin. The
toxic model OPs agent was paraoxon (POX) since it has similar
physicochemical properties than some highly toxic OPs (VX, soman,
etc.) [7] but it is much less toxic, making it safer to handle.
2. Experimental
2.1. Reagents and instrumentation
All reagents were obtained from Sigma–Aldrich. Microwave
treatment of the samples was  realized in a Multiwave 300 (Anton
Paar). The crystalline structure was identiﬁed by X-ray diffrac-
tion (XRD) using the Cu K wavelength ( = 0,1542 Å) of a X’Pert
Pro X-ray diffractometer from PANanalytical. The speciﬁc surface
area of the samples was measured by the Brunauer–Emmett–Teller
(BET) method with a Nova 1000 high speed gas sorption analyser
from Quantachrome. IR spectra were recorded on FTIR Spectrome-
ter PARAGON 1000 from PerkinElmer by potassium bromide pellet
method.
2.2. NPs synthesis and characterisationPure CeO2 powders were synthesized by a microwave-
hydrothermal method, previously published [39]. Brieﬂy a
0.5 mol/L cerium nitrate solution Ce(NH4)2 (NO3)6 was mixed with
2 mol/L sodium hydroxide solution at room temperature (∼20 ◦C).
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Cig. 2. XRD patterns of the pure (blue) and the doped CeO2 (red) nanoparticles.
he mixture was introduced in a silicon carbide crucible and treated
n a microwave during 15 min  at 90 ◦C and maximum pressure of
0 bars. The resulting precipitate was recovered by centrifugation,
ashed three times with deionized water and dried in air during
 h. The obtained compound was then treated in air at 500 ◦C during
 h. The calcium doped CeO2 powders were synthesized by adding
 Ca(NO3)2,4H2O solution to the initial solution in order to obtain
he ﬁnal doping at 15 mol.% of Ca2+. This percentage was chosen to
chieve the recommended dose of doping to observed a gain in the
fﬁciency of UV protection (>10%) [32].
The XRD patterns of the pure and the doped CeO2 nanoparticles
how that they only contain the CeO2 phase, which has a ﬂuorite
ype cubic structure (JCPDS 34-394) (Fig. 2). Physicochemical prop-
rties are presented in Table 1. The CeO2 lattice parameter increases
ith doping NPs, due to the Ca2+ effective ionic radius (1.12 Å),
hich is larger than that of Ce4+ (0.97 Å). The crystallite size was
alculated by Sherrer’s formula.
.3. Dispersion of NPs in emulsions
Three O/W emulsions containing 5% of perﬂuorinated polymers
PTFE, Polymist F5a), 5% silicones (standard dimethicone) and 10%
arafﬁn associated with or without cerium NPs were prepared:
21, H21CeO2 and H21CeO2–Ca2+. Commonly, the rate of active
ngredients is from 2% to 25% of the formula then we chose to use
P at 10%. H21 base did not contain NPs, H21CeO2 contained 10%
f pure CeO2 NPs and H21CeO2–Ca2+ contained 10% of Ca2+-doped
eO2 NPs.
.4. Synthesis and characterization of CeO2 grafted to HASE
opolymer
.4.1. Functionalization of NPs
2 g of CeO2 NPs, obtained from Truffault et al. [32] (diameter:
.3 nm,  crystallite size: 9.3 nm and lattice parameter: 0.5410) were
unctionalized as described previously [41]. The amount of amino
roups was determined by elemental analysis: 0.86 mmol/g.
IR (main vibrations):  = 3420 cm−1 (hydroxyl groups ( OH)
f Ce OH and water), 2925 cm-1 (alkyl groups of amino-silane
able 1
ristallite size, Lattice parameter and speciﬁc surface of CeO2 and Ca2+-doped CeO2.
Compound Cristallite size (nm) 
CeO2 10.60 
15%  Ca2+-doped CeO2 6.17 Fig. 3. FTIR spectrum of HASE-F/Ce in neutral (black curve) and basic middle (red
curve).
( CH2)), 1630 cm−1 (hydroxyl groups of water ( OH)), 1500 cm−1
(N H vibration of amine), 450–500 cm−1 (Ce O Ce vibration).
2.4.2. Grafting of NPs to the HASE copolymer
Functionalized CeO2 NPs were grafted on ﬂuorocarbon copoly-
mer  previously synthetized (HASE-F containing 13.5 mol.% of long
ﬂuorinated chain). The reaction was  similar to that realized for sil-
ica NPs in a previous work [41] excepted that the equivalent ratio
between NH2 and COOH groups was  0.13 eq (2.6 mmol of NH2)
for CeO2 NPs instead of 0.3 eq (5.7 mmol  of NH2). Fig. 3 represents
FTIR spectra of HASE-F/Ce in neutral and basic aqueous solution.
In basic medium, the carboxylic acid ionizes and the correspond-
ing carbonyl band is shifted from 1704 cm−1 to 1570 cm−1 (strong
asymmetrical stretching band) whereas the amide carbonyl band
stays at 1638 cm−1 and the ester one at 1741 cm−1. Moreover, in
basic and neutral medium the ﬂuorocarbon band, C O ester band,
and Ce O Ce band are at 1285 cm−1, 1170 cm−1, and 523 cm−1,
respectively. IR analysis showed the presence of residual free car-
boxylic acid functionalities that are necessary for the swelling of the
resulting compound in water and the dispersion of nanoparticles
in solution.
2.5. In vitro permeation studies
In vitro studies were conducted under a hood at room tempera-
ture (∼20 ◦C).
2.5.1. Preparation of silicone membranes
A roll of silicone membrane of 400 ± 100 m thickness was  pro-
vided by Samco Silicone Products (Nuneaton, UK). On the day of
experiment, it was cut into 9.42 cm2-surface area disks that were
then soaked in distilled water for 30 min.2.5.2. Diffusion cells and receptor ﬂuid
Franz-type glass diffusion cells (Laboratoires VERRE LABO-
MULA, Corbas, France) had 2-mL and 4-mL donor and receptor
compartments, respectively. The membrane area available for
Lattice parameter (nm) Speciﬁc surface (m2/g)
0.5410 10.66
0.5414 26.82
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Table 2
Efﬁcacy of formulation.
Compound n Jmax (%Q0/h)  (min) E = /Jmax %Q0 (end of exposure)
Silicone membrane 9 0.30 ± 0.05 45 ± 28 1a 1.37 ± 0.22
H21  base 6 0.18 ± 0.02 45 ± 16 1.7a 0.98 ± 0.09
H21  CeO2 6 0.13 ± 0.03* 70 ± 7 4.0b 0.53 ± 0.15*
H21CeO2–Ca2+ 6 0.10 ± 0.02* 72 ± 23 5.1b 0.42 ± 0.06*
HASE-F polymer 4 0.12 ± 0.04* 106 ± 52 6.2b 0.61 ± 0.11*
HASE-F/Ce polymer 6 0.08 ± 0.05* 86 ± 12 10.7c 0.28 ± 0.26*
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* Show signiﬁcant difference with unprotected control (silicone membrane) (p-v
iffusion was 1.13 cm2. Hank’s Buffer Saline Solution (HBSS) was
sed as receptor ﬂuid. The receptor compartments of the diffusion
ells were immersed in a water bath setting at 36 ◦C to get a mem-
rane surface temperature of 32 ± 1 ◦C on a magnetic stirrer bed.
hey contained a magnetic stir bar that allowed continuous mixing
f the receptor ﬂuid.
.5.3. Application of formulations
Twenty minutes prior to POX exposure, 5.0 ± 0.3 mg/cm2 of
mulsions or polymers were applied on the membrane surface as
omogenously as possible with a gloved ﬁnger.
.5.4. Dosing
POX was loaded on the middle of the membranes as a liquid
roplet (5 mg/cm2, i.e. 4.9 l) by using a positive displacement
ipette (Microman M10, Gilson). The exposure duration was 6 h.
.5.5. Sampling
Four hundred microliters of receptor ﬂuid (RF) were collected
egularly from 1hour and 30 min  to the end of the exposure dura-
ion. The replenishment of same volume of fresh receptor ﬂuid was
erformed at each sampling time.
.6. Quantiﬁcation of POX
The concentration of POX in the receptor ﬂuid samples was
etermined by using an enzymatic method already described
7,51]. A stock solution of POX (100 mM)  was prepared by the dilu-
ion of neat POX in absolute ethanol and stored at −20 ◦C. When
equired it was diluted to yield standard solutions from 1 to 25 nM.
tock solution of horse butyrylcholinesterase (BChE) and butyrylth-
ocholine iodide (BTCh) were prepared respectively at 1 mg/mL  and
5 mM in HBSS and stored at +4 ◦C. Immediately prior to use, the
ChE stock solution was diluted 25-fold (“enzyme solution”) and
he BTCh stock solution was diluted 10-times (“substrate solu-
ion”). The enzyme control (100% activity) consisted of 980 l of
nzyme mixed to 20 l HBSS (repetition of 3 different cuvettes). In
ach cuvette, 20 L of appropriately diluted samples of unknown
OX concentration or standards of known POX concentration were
ixed with 980 l of enzyme. Cuvettes were covered with a sealing
ape then incubated for 2 h at room temperature. 100 L of the sub-
trate was then added to each cuvette and the change in absorbance
ith time was measured spectrophotometrically at 400 nm over
 min. Standard curves were obtained by plotting the concentra-
ion of POX standards versus the logarithm of the percent of enzyme
ctivity remaining in each set of standards. The concentrations of
OX in samples were derived from the linear portion of the cali-
ration curve. All spectrophotometric measurements of enzymatic
eaction rates were performed at 30 ◦C using a UV/VIS spectropho-
ometer (LAMBDA 35, PerkinElmer).p < 0.05).
 0.05).
2.7. Data analysis
The cumulative amount of POX, expressed as percent of the
applied dose (%Q0), was  plotted against time. For each replicate,
maximal ﬂux (Jmax) values were calculated from the slope of the
graph determined after equilibrium was reached, i.e. when the POX
penetration rate became constant and maximum. The intercept of
this slope with the x-axis corresponds to the apparent lag time ().
2.8. Formulations efﬁcacy
As described in previous works [6,7], we chose to evaluate the
barrier efﬁcacy of products against POX from the ratio E = %/%Jmax
(% of control values). Ideally, membranes pre-treated with an effec-
tive TSP should delay (higher ) and slow down (lower Jmax)
the permeation of targeted chemicals. Formulations with E values
higher than 1 (i.e. delaying and/or slowing down the permeation
of POX) could be potentially effective as TSP. Conversely, products
with E values equal to or lower than 1 could be viewed as having
no effect or enhancing the permeation of POX, respectively.
2.9. Statistical analysis
Multivariate analysis of variance with the Kruskal–Wallis post-
hoc test followed by the Dunn test (two-tailed p-value) comparing
unprotected silicone membranes (controls) with protected ones
(emulsions or polymers) were performed at each time of the pen-
etration kinetic and for the Jmax,  and E parameters. Moreover,
one-way ANOVA tests followed by unilateral Dunnett tests were
used to determine whether these values were signiﬁcantly lower
or higher than the control group. A p-value lower than 0.05 was  con-
sidered signiﬁcant. All values were presented as mean ± SD (n = 6).
The statistical software was  XLSTAT.
3. Results
Firstly, the effect of NP on the efﬁcacy when introduced in emul-
sion (Fig. 4) or when grafted (Fig. 5) were studied. Secondly, the
dispersion of CeO2 NP in formula vs. in polymeric matrix were
compared (Table 2). Due to their standard deviation all  were
considered similar to unprotected controls (Table 2).
3.1. Effectiveness of emulsions
The base emulsion (H21) did not show an effective protection
(Fig. 4, Table 2). Emulsion containing pure CeO2 NPs or Ca2+-doped
CeO2 NPs showed the same signiﬁcant decrease of POX penetration
in comparison to unprotected control. Maximal ﬂuxes were 42%
(CeO2) and 33% (CeO2–Ca2+) of the control (Table 2). Amount of
POX recovered in the receptor ﬂuid at the end of exposure were
2–3-times reduced (Fig. 4, Table 2). The efﬁcacy of formulated CeO2
and Ca2+-doped CeO2 NPs were conﬁrmed by their E values being
greater than 1 (respectively 4.0 and 5.1).
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.2. Effectiveness of polymers
Both polymers showed a signiﬁcant reduction of the maximal
ux, from a 2-fold factor for HASE to 4-fold for CeO2 NPs grafted
o HASE polymer (Table 2). Penetrated percent of POX recovered in
he receptor ﬂuid at the end of exposure was 2–5-times reduced
Fig. 5, Table 2). The effectiveness of both polymers was conﬁrmed
y their E values signiﬁcantly greater than 1 (Table 2). Moreover,
he E value of HASE-F/CeO2 polymer was signiﬁcantly greater than
he E value of HASE-F polymer (10.7 vs. 6.2) (Table 2, p < 0.05).
.3. Comparative efﬁcacy of the two dispersions ways of CeO2 NPs
The comparison of CeO2 NPs dispersed in emulsion or grafted
o HASE-F polymer also provides information on how the graft-
ng inﬂuences overall efﬁcacy. E values show signiﬁcant differences
etween formulated and grafted CeO2 (4.0 vs. 10.7) (Table 2). Then
he grafting positively impacts the efﬁciency of CeO2 NPs.
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4. Discussion
To evaluate the efﬁcacy against organophosphate POX we use
in vitro permeation tests through silicone membranes as ﬁrst
screening tests. In this work, we  study the best way to disperse and
improve the protectant efﬁcacy of cerium NPs. Firstly we measure
the contribution of CeO2 NPs on the protection efﬁciency. Secondly,
since the doping of CeO2 NP by calcium enhances the effectiveness
for UV protection [32], we study its potential effect on the protec-
tion against OPs penetration by comparing effectiveness of pure
and doped NPs dispersed in O/W emulsions. Finally, we study the
inﬂuence of the two dispersion methods on the efﬁciency. Thereby,
we compare the effectiveness of NPs dispersed in emulsion and
once grafted to a new ﬂuorocarbon HASE polymer.
4.1. Positive effect of CeO2 NPs in formulations
The emulsion base (H21 base) is composed of 5% of PTFE, 5%
of silicone and 10% of parafﬁn. These ingredients were chosen for
their ﬁlm-forming properties so as to create a barrier against the
POX penetration. Moreover, perﬂuorinated polymers have a known
effectiveness in TSP [16,52] due to their low surface tension energy
giving them oleophobic and hydrophobic properties [53]. However,
the H21 emulsion used as reference control does not show any efﬁ-
ciency. The ineffectiveness of the base emulsion can be explained:
(1) silicone and parafﬁn are hydrophobic and lipophilic ingredients,
they probably create afﬁnity with the tested lipophilic agent POX
and (2) the H21 base emulsion is composed with 5% of PTFE. Efﬁ-
cient perﬂuorinated-based TSP such as SERPACWA are composed
with 100% perﬂuorinated compounds (50% of perﬂuoropolyether
oil and 50% of PTFE) [52]. 5% of PTFE on the H21 base emulsion is
not sufﬁcient to provide an effective protection. The addition of
the CeO2 and calcium doped-CeO2 NPs into H21 base emulsion
(H21CeO2 and H21CeO2–Ca2+) induces a signiﬁcant effectiveness
in comparison to unprotected controls (E = 4.0–5.1). Therefore, the
efﬁciency of H21CeO2 and H21CeO2–Ca2+ emulsions in compari-
son to the H21 base demonstrates that the protection is due to the
presence of NPs.
Perﬂuorinated HASE polymer (HASE-F) show an efﬁcient protec-
tion against the penetration of POX (E = 6.2). The grafting of NPs onto
polymer allows to disperse them easily in water thanks to the rhe-
ological properties of the HASE polymers that form physical gels in
water at neutral pH. Thereby, neutralized suspension in water con-
taining 10 wt.% of polymer or grafted polymer can be easily spread
on silicone membrane. HASE-F/CeO2 formulation shows a better
efﬁciency in comparison to HASE-F (E = 10.7). Therefore, we demon-
strate that (1) the application of ﬂuorocarbon HASE polymer on
silicone membrane reduces by half the permeation of POX, thanks
to the repellent properties of the ﬂuorinated polymer and (2) as well
as for emulsions, the presence of CeO2 NPs signiﬁcantly reduces the
permeation of POX as they are known to be active agents for their
adsorption and degradation properties [11,22,25–27,34,54].
Moreover, Millerioux et al. [7] tested, with silicone membrane,
the protective efﬁcacy of O/W emulsion (BCw E = 1.03) and per-
ﬂuorinated polymers-based cream (BCp E = 230) against POX. Our
emulsions and polymers containing NPs show a better protective
efﬁciency than BCw due to the addition of NPs (E value respec-
tively, 4.0 for H21CeO2; 5.1 for H21CeO2–Ca2+; 6.2 for HASE-F and
10.7 for HASE-F/Ce). However, both NPs emulsions and polymers
are less protective than BCp. BCp is a perﬂuorinated compounds-
based barrier cream composed of 100% ﬂuorinated compounds and
difﬁcult to spread, used here as a positive control. Therefore, the
introduction of NPs in an emulsion or onto a thickener allows to
create an efﬁcient barrier against the penetration of POX that is less
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xpensive due to a lower amount of perﬂuorinated compounds and
ith better spreading properties.
.2. Effect of the doping by calcium of CeO2 NP for skin protection
Doping of CeO2 NPs by calcium increase their UV ﬁltration and
akes its better to use for the solar skin protection [32]. It could be
nteresting to see if some similar properties could be observed for
he skin protection against the penetration of OPs. The 15 mol.%
f Ca2+ doping was chosen to reach the recommended dose to
bserved a gain in the efﬁciency of UV protection (>10%) [32].
21CeO2 and H21CeO2–Ca2+ have the same protection efﬁciency
respectively, E = 4.0 and 5.1). The compared efﬁciency between
oth type of NPs introduced in emulsion does not highlight any
nhanced efﬁciency of Ca2+-doped CeO2. Thus, the doping and the
bserved modiﬁcations of physicochemical properties are not suf-
cient to impact signiﬁcantly the effectiveness of CeO2 NPs in the
ase of OP skin protection.
The advantage of the emulsion formulation is to disperse active
ngredients (NPs) in a matrix at lower cost and with good spread-
bility. Moreover, thanks to the presence of the ingredients, the
oating is homogenous and ﬁlm-forming that allows a good repro-
ucibility of the results. Indeed, at the end of exposure, the relative
tandard deviation (RDS = SD/mean) of the percent of the initial
ose (%Q0) is nearly the same as unprotected control (16%): H21,
%; H21CeO2, 21%; H21CeO2–Ca, 14%. But, due to their size and their
igh active surface NPs aggregate easily in aqueous solution mak-
ng its difﬁcult to realize homogeneous dispersions. Moreover, at
he nano-state they can be an issue for safety assessments [35–40].
n that context, we propose a new approach to disperse NPs in for-
ula: their covalent grafting onto HASE polymers that limit their
oxicological impact on the environment [50].
.3. Efﬁciency of CeO2 NPs in emulsion or grafted to a thickening
olymer
Since pure and calcium doped-CeO2 NPs having the same pro-
ection, we choose to graft only the pure NPs. The advantages of the
rafting are (1) to conserve the high active surface of NPs by better
ispersing NPs and keeping them at the individual state [41] and
2) to limit the potential toxicological impact thanks to the covalent
rafting of NP on a polymeric matrix [50]. The dispersion by graft-
ng NPs to a thickening polymer (EHASE-F/CeO2 = 10.7) show a better
ffectiveness than the dispersion in emulsion (EH21CeO2 = 4.0). How-
ver, the deposit of the grafted polymer can slightly crack during
he drying. Indeed, at the end of exposure, the relative standard
eviation (RDS = SD/mean) of the percent of the initial dose (%Q0)
s 5-time higher for the HASE-F/CeO2 (92%) than the HASE-F (18%,
imilar to unprotected membranes). The same ratio is observed for
he Jmax (39% for HASE-F/Ce polymer and 19% for the H21CeO2
mulsion). Although the CeO2 NPs grafted onto HASE-F polymer
how a better effectiveness, the risk of a cracking increases appre-
iably the standard deviation of our results. Thus, the choice is
 compromise between a good effectiveness or a ﬁlm-forming
preading and a good reproducibility.
. Conclusion
In this work, we demonstrated that relative to CeO2 NPs, Ca2+-
oped CeO2 NPs do not enhance efﬁciency for the skin protection
gainst the penetration of OP toxic agent POX. We  also studied
wo ways to integrate CeO2 NPs in TSP: formulating them into
/W emulsions or grafting them on the ﬂuorocarbon associative
olymer (HASE-F). These two formulations were more effective in
omparison to their base (H21 base and HASE-F polymer): the use of
[
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NPs enhances protection properties. This tendency must be veriﬁed
by other in vitro tests using excised pig or human skin.
In conclusion, the emulsion formulation is the best way to obtain
ﬁlm-forming coating allowing a good reproducibility of the pene-
tration results. However, the use of free NPs as an active ingredient
has two  main issues: they can easily aggregate in emulsion and
they can induce a possible healthy risk since NP penetration and
accumulation in biological membranes is suspected. On the con-
trary, the grafting of NPs on ﬂuorinated polymeric matrix link them
covalently to macromolecules that allows to disperse them homo-
geneously without any toxicological issues of the NPs. But, the
deposit cracks at drying and thus the reproducibility is impacted.
Therefore, the best way to disperse NPs could be to introduce the
grafted polymer in a ﬁlm-forming formula.
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